Clinical Trial

Gait Assessment Via Telephone Application

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 24, 2025 (before its estimated July 2025 completion). Its status may not reflect the trial's current state.
Summary
The evaluation of human gait is a crucial component of the clinical assessment and decision-making process. The gold standard in gait analysis is computerized gait analysis, which allows for three-dimensional digital data acquisition through computers (3D Computerized Gait Analysis). However, this technology is not readily accessible in routine analyses, as it proves to be a time-consuming and expensive endeavor in terms of infrastructure and human resources. The utilization of smartphones in clinical applications is on the rise, facilitated by the increasing accessibility of low-cost or free "applications," thereby addressing the limitations associated with traditional gait analysis methods. The Gait-Analyzer application is among the mentioned applications. However, in the literature, no evidence has been found regarding the validity and reliability of Gait-Analyzer application compared to the gold standard 3D computerized gait analysis systems within the context of gait analyses. The aim of this study is to comparatively examine the effectiveness of the Gait-Analyzer smartphone application with established 3D Computerized Gait Analysis systems, which have proven validity and reliability in gait analyses. Through this research, the study intends to elucidate the validity and reliability of spatiotemporal parameters of walking within the Gait-Analyzer smartphone application.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2023-11-27; most recent amendment 2025-03-21.
Status change: Not Yet Recruiting → Recruiting 2024-07-30
Trial Details
NCT Number NCT06157749
Lead Sponsor Istanbul University - Cerrahpasa
Conditions Health, Subjective
Enrollment 34 participants
Start Date 2024-07-31
Primary Completion 2025-07 (estimated)
Study Completion 2025-09 (estimated)
Updated on ClinicalTrials.gov 2025-03-24